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Summary The South Australian Breast X-Ray Service is a centralised breast cancer screening programme in
the State of South Australia. In its first 5 years of operation nearly 100 000 screens were performed. This study
reports the clinical performance of the programme and compares it with other published series. Women aged
40 years and over were screened with two-view mamography every 2 years. Radiologists double-read the
screening films and multidisciplinary teams assessed the recalled women at a single centre. In the prevalent
round 76106 women were screened, and subsequently 21 506 of them were rescreened. The recall rate for
further investigation was 4.9% in the prevalent round and 2.4% in the incident rounds. The cancer detection
rate per 1000 women was 7.0 in the prevalent screening round and 3.4 in the incident rounds. Forty-two per
cent of invasive carcinomas measured < 10 mm in the prevalent screening round and the median tumour size
was 12 mm. The benign to malignant biopsy ratio was 1: 1.4 in the prevalent round and 1: 2.8 in the incident
rounds. In the prevalent round 77% of invasive tumours were lymph node negative and this proportion
increased to 86% in the incident rounds.
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A significant reduction in breast cancer mortality through
mammographic screening has been demonstrated in the New
York Health Insurance Plan (Shapiro et al., 1971) and the
Swedish two-county trial (Tabar et al., 1989). Further
evidence of the benefit of mammography has been obtained
from other studies in the Netherlands (Collette et al., 1984),
the USA (Morrison et al., 1988) and Italy (Palli et al., 1989),
from the overview of all the Swedish trials (Nystrom et al.,
1993) and from combined analyses (Fletcher et al., 1994;
Wald et al., 1994).
In the late 1980s, ten pilot screening projects, including the
South Australian Breast X-Ray Service (SABXRS), were
established throughout Australia. In February 1991 the
SABXRS, a branch of the SA Health Commission, joined
the National Program for the Early Detection of Breast
Cancer, which is a joint Commonwealth/State initiative, and
developed into the statewide mammographic screening.
programme.
The state of South Australia covers an area of 987 170
square kilometres and has a population of 1.5 million people,
of whom approximately 133 000 are women aged 50-69.
Nearly 75% of the population reside in the capital city,
Adelaide.
The SABXRS was modelled largely on the Swedish two-
county trial. However, operational differences between these
services include SABXRS's use ofmultiple radiologist readers
and multidisciplinary assessment teams and are influenced by
the geographical area, which is approximately twice that of
all Sweden.
Materials and methods
The SABXRS provided free mammographic screening every
2 years to women aged 40 years and over with two views of
each breast, the mediolateral oblique and craniocaudal
projections. There was active recruitment in the age group
50-69 years but women aged 40-49 years and greater than
69 years were screened at their request. Recruitment
strategies were based on personal invitations derived from
the electoral roll and general practitioners (Dorsch et al.,
1991). Women in the age group 40-49 with a strong family
history of breast cancer were offered annual screening.
Women with significant symptoms or a past history of
breast cancer who attempted to make an appointment with
the screening programme were encouraged to consult their
general practitioners instead and to be referred for diagnostic
mammography services if appropriate. However, if women
presented to screening with a breast lump, they had an
additional lateromedial view taken with a lead skin marker
over the lump but were not automatically recalled to the
assessment clinic unless suspicious mammographic features
were detected.
Screening was performed at five mammographic units
located within metropolitan Adelaide and a mobile mammo-
graphic van, which began operation in 1992. The mammo-
graphic images were acquired using G.E. Senograph 600T
and DMR units and the Kodak MinRE-1 film was processed
using Kodak chemicals with extended dwell time in the
developer (47 s) at a temperature of 36°C. Films from the
mobile unit were processed in Adelaide. The mammograms
were independently double-read and reported by a total of 17
radiologists at the Adelaide centre and the reports were
combined into a single recommendation. In the case of
discrepancy between the two primary readers regarding the
decision to recall a woman, the films were read by a third
radiologist, who determined the final recall status.
The centralised assessment clinic was staffed by multi-
disciplinary teams comprising radiologists, radiographers,
medical officers, nurse counsellors, cytopathologists and
surgeons. Fine needle aspiration (FNA) cytology was
reported within the assessment clinics. Stereotactic or
ultrasound guidance was used for impalpable lesions. Those
requiring excision were localised using either a carbon track
(Langlois and Carter, 1991) or hookwire. Initial counselling
and recommendations for treatment were made to women in
whom the diagnosis of breast cancer was made at assessment.
Surgical (open) biopsy and treatment were not provided as
part of the South Australian programme and management
was arranged in collaboration with the woman's general
practitioner. Further information was retrieved from
surgeons and pathology laboratories in all cases. The data
were coded according to the requirements of the Australian
national breast screening programme (National Accreditation
Committee, 1994). Tumour size was taken from the
histopathology report as the maximum dimension of an
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invasive carcinoma. Tumours were coded as 'micro-invasive
carcinoma' when the histopathology report described
predominant ductal carcinoma in situ (DCIS) with only
microscopic or minimal stromal invasion. Lobular carcinoma
in situ was not coded as a malignancy. Stage was determined
according to the TNM system (Hermanek and Sobin, 1992).
There was an audit of all biopsy cases by a radiologist (JIR)
and pathologist (JMK). The majority was reviewed at regular
multidisciplinary meetings. Data were stored on a database
system designed by the SABXRS and programmed by the
computing branch of the South Australian Health Commis-
sion. Information regarding cancers diagnosed between
mammographic screens (interval cancers) was provided by
the South Australian Central Cancer Registry.
Results
Between 1 January 1989 and 31 December 1993, 76 106
women were screened and 21 506 of these were rescreened,
making a total of 97 612 examinations. Numbers of women
screened and their age distribution are shown in Figure 1.
During the first 2 years of the programme, while in its pilot
phase, only women aged 50-69 years were screened.
In the prevalent round 17 761 women (23.3%) were aged
40-49 years, 55 700 (73.2%) were aged 50-69 years and
2645 (3.5%) were aged 70 years and over. In the incident
rounds 2320 women (10.8%) were aged 40-49 years, 18 945
(88.1%) were aged 50-69 years and 241 (1.1%) were aged 70
years and over.
40 000
35 000
'a
c; °D 30 000
a)
0
25 000 c
a)
E
o 20 000
0
E0 10000
z
5000
A
1989 1990 1991 1992 1993
Year
Figure 1 Numbers of women screened per year (all screening
rounds). Age in years: *, >70; M 50-69; El, 40-49.
Prevalent round Incident rounds
Figure 2 Work scheme of the prevalent and incident screening rounds. Nine had no surgery, two had lesion missed at surgery.
+Two had lesion missed at surgery.
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vApproximately 42% of women in South Australia's target
age group of 50-69 years were screened. Symptomatic
women with a breast lump or blood-stained nipple discharge
represented 3.0% of the prevalent screens and 2.3% of the
incident screens. There were 251 women (0.3%) who had a
past history of breast cancer. Mammography had previously
been performed outside the screening service in 18 999
women (25.0%) but their first screening mammogram with
the SABXRS was still considered part of the prevalent round.
Of the 76 106 women screened in the prevalent round,
3761 women were recommended for assessment (4.9%). Of
the 21 506 women who were rescreened in incident rounds,
523 (2.4%) were recommended for assessment.
Assessment
The assessment outcome has been summarised in Figure 2. In
the prevalent screening round 535 malignancies were
diagnosed or confirmed histologically. This corresponds to
a cancer detection rate of 0.7% of the women screened and a
surgical biopsy rate of 1.2%. The proportion of surgical
biopsies positive for malignancy (positive predictive value)
was 58%. The benign to malignant surgical biopsy ratio was
1:1.4.
In the incident screening rounds 74 malignancies were
diagnosed or confirmed histologically. The cancer detection
rate was 0.34% and the surgical biopsy rate was 0.5%. The
positive predictive value of surgical biopsy was 74%. The
benign to malignant surgical biopsy ratio was 1: 2.8.
Fine needle aspiration (FNA) cytology was performed on
two-thirds of the women referred for surgical biopsy in all
screening rounds. FNA established the diagnosis of breast
cancer in 284 of the 480 women with breast cancer in whom
it was performed (59% absolute sensitivity) and gave
suspicious or atypical results in a further 128 of these
women (86% complete sensitivity) (Cytology Subgroup,
1994). No false-positive diagnosis of malignancy was made
by cytology.
Cancer size, nodal status and histological classification
Table I summarises the size and axillary nodal status of the
primary invasive breast carcinomas detected. There were 94
cases of DCIS, accounting for 17.6% of all primary breast
carcinomas in the prevalent screening round and 12 cases
(16.4%) in the incident screening rounds. Small invasive
tumours, 10 mm or less in diameter, represented 42% of the
invasive breast cancers in the prevalent screening round and
41% in the incident screening rounds. The median tumour
size was 12 mm in all rounds. In the prevalent screening
round 77% of the invasive tumours were lymph node
negative and in the incident screening rounds this proportion
increased to 86%.
The histological classification of all malignancies, includ-
ing metastatic and non-epithelial malignancies has been
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summarised in Table II. There were five cases of lobular
carcinoma in situ and 53 cases of atypical hyperplasia
included among the 408 benign biopsies. Bilateral breast
cancers were detected in ten women, but the lesions in the
contralateral breast were not counted as additional cancers.
Stage 0 and stage I tumours represented 75% of the
tumours detected in the prevalent screening round and 81%
of the tumours detected in the incident screening rounds
(Table III).
Interval Cancers
The interval cancer rate was calculated from the number of
cancers diagnosed within 1 year of screening because of the
short time from completion of the study. The final year ofthe
study was also excluded from the data to avoid under-
estimation of the rate by pending cases. Twenty-six such
cancers were diagnosed in the 47 653 women screened in the
prevalent round to 31 December 1992. This corresponds to
an interval cancer rate of 0.5 per 1000 women screened.
Table II Histological types of all malignancies (all screening
rounds)
Histological type Number (%)
Ductal carcinoma in situ 106a 17.4
Infiltrating carcinoma of no special type 422 69.4
Infiltrating lobular carcinoma 31 5.1
Tubular or invasive cribriform carcinoma 38 6.2
Mucinous carcinoma 5 0.8
Medullary carcinoma 2 0.3
Invasive papillary carcinoma 2 0.3
Other types 3 0.5
Total 609 100
aTwo cases ofDCIS were non-invasive papillary carcinomas. bOne
case each of malignant phyllodes tumour, metastatic melanoma in
breast, metastatic carcinoma in axillary node from previous breast
cancer. Not included in Tables I and III.
Table Ill Stage of primary breast carcinomas detected
Prevalent round Incident rounds
Stage Number (%) Number (%)
0 94 (17.6) 12 (16.4)
I 307 (57.6) 47 (64.6)
II 113 (21.2) 14 (19.2)
III 9 (1.7) 0 (0)
IV 0(0) 0 (0)
Unknown 10 (1.9) 0 (0)
Total 533 (100) 73 (100)
Table I Size and axillary nodal status of the primary invasive breast carcinomas
Prevalent round Incident rounds
Invasive Number Number Number Number
carcinoma Number with axillary with nodal Number with axillary with nodal
size (mm) (%) dissection metastases (%) dissection metastases
Microinvasive 22 (5) 18 0 2 (3) 2 0
1-10 163 (37) 151 20 23 (38) 22 0
11-15 109 (25) 106 24 18 (30) 17 3
16-20 74 (17) 71 18 8 (13) 8 1
21-30 37 (8) 36 18 7 (11) 7 3
31-50 18 (4) 18 13 3 (5) 3 1
>50 3(1) 2 2 0 (0) 0 0
Size unknowna 13 (3) 10 1 0 (0) 0 0
Total 439 (100) 412 96 61 (100) 59 8
aSize not stated in pathology report or no surgery performed.Breast cancer screening in South Australia
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Table IV Prevalent and incident screen resultsa
SABXRS Central Sydney Essendon
Number screened
Recall rate
Cancer detection rate
76106
(21 506)
4.9%
(2.4%)
0.7%
(0.3%)
7193
16.5%
0.7%
16424
9.2%
0.81%
Two-county Stockholm Uppsala
69645 71085 37468
(62 100) (36842) (32555)
4.9%
(3.3%)
0.6%
(0.3%)
3.7%
(1.5%)
0.7%
(0.4%)
4.6%
(5.7%)
0.5%
(0.5%)
PPVb of biopsy
DCIS rate
Invasive cancers < 10 mm
56%
(73%)
18%
(16%)
42%
(41%)
53%
23%
37%
56%
18%
46%
50%
(75%)
8%
(10%)
73%
13%
(16%)
56%
(63%)
11%
(15%)
42%
58%
20%
40%
Node-negative invasive cancers 77% 78% - 79% 80% 79% 91%
(86%) - - (83%) (77%) (83%)
aFigures in brackets represent results from incident screening rounds. See Discussion for references. bPositive predictive value.
Treatment
Surgical treatment was performed on 601 cases of primary in
situ and invasive carcinoma. Of these women, 365 (61%) had
breast-conserving surgery. Total mastectomy was performed
in the remaining 236 women (39%). Four women in whom
the diagnosis of breast cancer was made by cytology either
refused surgery or were unsuitable for surgical treatment. The
surgical managment was unknown for one case.
Discussion
Individual state mammographic screening programmes
throughout Australia have used different strategies, accom-
modating local conditions, to conform with accreditation
guidelines set by the National Program for the Early
Detection of Breast Cancer (National Accreditation Commit-
tee, 1994). The SABXRS has the largest throughput of any
single breast screening and assessment service in Australia.
Features of the programme include the extensive geographi-
cal area that it covers, the large number of radiologist
readers, the complete centralisation of reading and assess-
ment services and the influence of multidisciplinary assess-
ment teams. The demographic and geographical features of
South Australia, in which the majority of the population is
located within one city, led to the logical siting of a
centralised reading and assessment centre in Adelaide.
The numbers of women screened in this programme were
similar to those of the Swedish two-county trial (Tabar et al.,
1985) and the Stockholm mammography screening pro-
gramme (Lidbrink et al., 1994) (Table IV). Two Australian
pilot projects, Central Sydney (Rickard et al., 1991) and
Essendon programmes (The Essendon Group, 1992), have
reported their results on smaller numbers of women screened
over a shorter period within urban areas. Although steady-
state screening levels had not been reached during this phase
of the South Australian programme, approximately 42% of
the female population aged 50-69 were included among the
screened women. Similar attendance rates in both rural and
metropolitan areas were achieved.
The SABXRS employed a larger number of radiologists
than the European programmes. Over half of the radiologists
read screening films for the duration of the study and four of
them read a large proportion of the screens. Continuous
monitoring and feedback of radiological performance has
been maintained by: (a) review of the screening and work-up
films of assessed women by all the radiologists on a weekly
basis; (b) provision of individual and group performance
statistics; (c) review of interesting and problem cases in
radiology and multidisciplinary meetings; (d) audit and
classification of interval cancers by the group. The
involvement of multiple radiologists could be seen as a
disadvantage by reducing reading consistency but this was
minimised by the quality assurance mechanisms described. In
addition, the readers were carefully matched and the 'third
readers' were a smaller and more experienced subgroup.
Stringent quality assurance mechanisms have also been
applied to radiographic techniques.
The use of a third reader rather than a consensus system
to determine the final outcome of discordant calls was
successful in achieving a low recall rate and maintaining a
high cancer detection rate. The recall rate in the prevalent
round (4.9%) was very similar to that of the Swedish two-
county (Tabar et al., 1984) and Uppsala studies (Thurfjell
and Lindgren, 1994) but lower than the two published
Australian studies (Rickard et al., 1991, The Essendon
Group, 1992). Possible factors contributing to this discre-
pancy are the use of the 'third reader' system, the smaller
number of technical recalls and the smaller proportion of
symptomatic women who were screened and assessed. In the
incident rounds the recall rate (2.4%) was approximately half
that observed in the prevalent screening round. This can be
explained by the availability of the previous films for review
at the time of reading and the lower incidence of breast
cancer in rescreened women.
Cancer detection rates were also very similar to those
reported in major European studies (Lidbrink et al., 1994,
Ellis et al., 1993, Tabar et al., 1992). During the same period
(1989-93) the South Australian Central Cancer Registry
reported a 21% increase in breast cancer incidence (South
Australian Cancer Registry, 1994). The women screened by
the South Australian programme were predominantly
asymptomatic. Only 7% of women with breast cancer
detected by screening presented with significant symptoms,
compared with 13% in both the other Australian studies
(Rickard et al., 1991, The Essendon Group, 1992). This may
have contributed to the higher cancer detection rates in those
two studies. Another factor that may influence cancer
detection rates is the number of women that present to
screening with prior mammography and that are therefore
not true 'prevalent screens'. Although this was the case in
approximately one-quarter of the women screened by the
SABXRS, the cancer detection rate remained high.
The referral rates for surgical biopsy and the positive
predictive values of biopsy also compared favourably with
other series. Fifty-nine per cent of women with breast cancer
in whom FNA was performed had a cytological diagnosis of
malignancy. Although this proportion was lower than the
65% reported in the Stockholm series (Lidbrink et al., 1994)
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and 74% in the Nottingham series (recalculated from Ellis et
al., 1993), it increased substantially in the latter part of the
study period when cytology was used more extensively. An
'on-site' cytology reporting service allowed establishment of
the diagnosis of breast cancer at the time of assessment so
that referral for definitive surgical management could be
made. The increased use of cytology during the study period
also led to a decrease in the number ofbenign open biopsies.
One of the most critical indicators of a screening
programme's success is its ability to detect a high proportion
of small invasive breast cancers. Because of differences in the
criteria used by individual screening programmes to classify
tumour size, it is difficult to make general comparisons. The
median tumour size of 12 mm was identical to that reported
by Sickles et al. (1990) and Lidbrink et al. (1994). Forty-two
per cent of all the invasive carcinomas detected by the
programme in the prevalent screening round measured
10 mm or less in diameter and 60% measured under
15 mm, the latter exceeding the target of 50% proposed by
Tabar et al. (1992) to achieve a substantial reduction in
mortality. The proportion of small invasive tumours
remained similar in the prevalent and incident rounds. The
DCIS rate was less than 20% and was comparable with the
other Australian and Nottingham studies.
The proportion of lymph node-negative invasive cancers
(77%) in the prevalent screening round also exceeded the
target proposed by Tabar (> 70%) and the majority of
breast cancers (75%) were stage 0 or stage I at diagnosis. The
South Australian Central Cancer Registry (1994) recently
recorded an increase in the proportion of early stage breast
cancers detected in screened women compared with non-
screened breast cancer patients who presented to teaching
hospitals, providing further evidence of the efficacy of
screening. The interval cancer rate was close to that observed
in the Stockholm (Frisell et al., 1987) and Uppsala (Thurfjell
and Lindgren, 1994) studies but was greater than that
reported in the Swedish two-county trial (Tabar et al.,
1987). However 2 year follow up data are not yet available
and a time-lag is also required to ensure that the data are
complete. A detailed analysis including comparison with
expected rates in the absence of screening will therefore be
the subject of a subsequent report.
The proportion of women treated with breast-conserving
surgery (61%) was high when compared with other published
series (Lidbrink et al., 1994, Harrison et al., 1994) but did not
achieve the levels reported in the latter period of the
Edinburgh trial (77%) (Roberts et al., 1990) and the
Essendon pilot project (82%) (The Essendon Group, 1992).
The results from this study demonstrate that a newly
established metropolitan-based screening programme, using
multiple radiologists and centralised reading and assessment
services, can achieve standards similar to successful published
studies. In future the SABXRS aims to achieve a reduction in
breast cancer mortality in South Australia by maintaining
and improving its performance during further expansion to
its target screening level of 60 000 women per year.
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